Actively Recruiting
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Led by IRCCS San Raffaele · Updated on 2025-06-11
2500
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024
CONDITIONS
Official Title
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prostate cancer patients older than 18 years
- Treated with Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), or Stereotactic Body Radiotherapy (SBRT)
You will not qualify if you...
- Presence of other tumors
- Older than 95 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS San Raffaele Scientific Institute
Milan, Italy, 20132
Actively Recruiting
Research Team
A
Andrei Fodor, MD
CONTACT
N
Nadia G Di Muzio, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here